Fertility and Sterility
Volume 95, Issue 1 , Pages 333-337 , January 2011

Peroxisome proliferator-activated receptor gamma and early folliculogenesis during an acute hyperandrogenism condition

  • Monica Faut

      Affiliations

    • Laboratorio de Fisio-patología Ovárica, Centro de Estudios Farmacológicos y Botánicos, Buenos Aires, Argentina
    • ,
  • Evelin Mariel Elia

      Affiliations

    • Laboratorio de Fisio-patología Ovárica, Centro de Estudios Farmacológicos y Botánicos, Buenos Aires, Argentina
    • ,
  • Fernanda Parborell, Ph.D.

      Affiliations

    • Instituto de Biología y Medicina Experimental, Consejo Nacional de Investigación Científica y Técnica, Buenos Aires, Argentina
    • ,
  • Noelia Melina Cugnata

      Affiliations

    • Laboratorio de Fisio-patología Ovárica, Centro de Estudios Farmacológicos y Botánicos, Buenos Aires, Argentina
    • ,
  • Marta Tesone, Ph.D.

      Affiliations

    • Instituto de Biología y Medicina Experimental, Consejo Nacional de Investigación Científica y Técnica, Buenos Aires, Argentina
    • Facultad de Ciencias Exactas, Universidad de Buenos Aires, Buenos Aires, Argentina
    • ,
  • Alicia Beatriz Motta, Ph.D.

      Affiliations

    • Laboratorio de Fisio-patología Ovárica, Centro de Estudios Farmacológicos y Botánicos, Buenos Aires, Argentina
    • Corresponding Author InformationReprint requests: Alicia Beatriz Motta, Ph.D., Centro de Estudios Farmacológicos y Botánicos, Consejo Nacional de Investigación Científica y Técnica, Paraguay 2155, Buenos Aires, Argentina (FAX: 00-54-11-4508-3680).

Received 9 May 2010 ,Revised 1 July 2010 ,Accepted 26 July 2010.

References 

  1. Fernandez-Fernandez R, Martín AC, Navarro VM, Castellano JM, Dieguez C, Aguilar E, et al. Novel signals for the integration of energy balance and reproduction. Mol Cel Endocrinol. 2006;254–255:127–132
  2. Iuorno MJ, Nestler JE. The polycystic ovary syndrome: treatment with insulin sensitizing agents. Diabetes Obes Metab. 1999;1:127–136
  3. Seli E, Duleba AJ. Treatment of PCOS with metformin and other insulin-sensitizing agents. Curr Diab Rep. 2004;4:69–75
  4. Musi N, Hirshman MF, Nygren J, Svanfeldt M, Bavenholm P, Rooyackers O, et al. Metformin increases AMP-activated protein kinase activity in skeletal muscle of subjects with type 2 diabetes. Diabetes. 2002;51:2074–2081
  5. Elia E, Sander V, Luchetti CG, Solano ME, Di Girolamo G, Gonzalez C, et al. The mechanisms involved in the action of metformin in regulating ovarian function in hyperandrogenized mice. Mol Hum Reprod. 2006;2:475–481
  6. Issemann I, Green S. Activation of a member of the steroid hormone receptor superfamily by peroxisome proliferators. Nature. 1990;347:645–650
  7. Komar CM. Peroxisome proliferator-activated receptors (PPARs) and ovarian function—implications for regulating steroidogenesis, differentiation, and tissue remodeling. Reprod Biol Endocrinol. 2005;3:41–55
  8. Higashiyama H, Billin AN, Okamoto Y, Kinoshita M, Asano S. Expression profiling of peroxisome proliferator-activated receptor-delta (PPAR-delta) in mouse tissues using tissue microarray. Histochem Cell Biol. 2007;127:485–494
  9. Froment P, Fabre S, Dupont J, Pisselet C, Chesneau D, Staels B, et al. Expression and Functional role of peroxisome proliferator-activated receptor-g in ovarian folliculogenesis in the sheep. Biol Reprod. 2003;69:1665–1674
  10. Ibabe A, Grabenbauer M, Baumgart E, Fahimi HD, Cajaraville MP. Expression of peroxisome proliferator-activated receptors in zebrafish (Danio rerio). Histochem Cell Biol. 2002;118:231–239
  11. Crawford MJ, Liversage RA, Varmuza SL. Two isoforms of Xenopus retinoic acid receptor gamma 2 (B) exhibit differential expression and sensitivity to retinoic acid during embryogenesis. Dev Genet. 1995;17:291–302
  12. Mohan M, Malayer JR, Geisert RD, Morgan GL. Expression patterns of retinoid X receptors, retinaldehyde dehydrogenase, and peroxisome proliferator activated receptor gamma in bovine preattachment embryos. Biol Reprod. 2002;66:692–700
  13. Wood JR, Dumesic DA, Abbott DH, Strauss JF. Molecular abnormalities in oocytes from women with polycystic ovary syndrome revealed by microarray analysis. J Clin Endocrinol Metab. 2007;92:705–713
  14. Huang Z, Zhou X, Nicholson AC, Gotto AM, Hajjar DP, Han J. Activation of peroxisome proliferator-activated receptor-alpha in mice induces expression of the hepatic low-density lipoprotein receptor. Br J Pharmacol. 2008;155:596–605
  15. Cui Y, Miyoshi K, Claudio E, Siebenlist UK, Gonzalez FJ, Flaws J. Loss of the peroxisome proliferation-activated receptor gamma (PPARgamma) does not affect mammary development and propensity for tumor formation but leads to reduced fertility. J Biol Chem. 2002;277:17830–17835
  16. Luchetti CG, Solano ME, Sander V, Arcos ML, Gonzalez C, Di Girolamo G, et al. Effects of dehydroepiandrosterone on ovarian cystogenesis and immune function. J Reprod Immunol. 2004;64:59–74
  17. Sander V, Solano ME, Elia E, Luchetti CG, Di Giorlamo G, Gonzalez C, et al. The influence of dehydroepiandrosterone on early pregnancy in mice. Neuroimmunomodulation. 2005;12:285–292
  18. Sander V, Luchetti CG, Solano ME, Elia EM, Di Girolamo G, Gonzalez C, et al. Role of the N, N’dimethylbiguanide metformin in the treatment of female prepuberal BALB/c mice hyperandrogenized with dehydroepiandrosterone. Reproduction. 2006;131:591–602
  19. Solano ME, Elia E, Luchetti CG, Sander V, Di Girolamo G, Gonzalez C, et al. Metformin prevents embryonic resorption induced by hyperandrogenisation with dehydroepiandrosterone in mice. Reprod Fertil Dev. 2006;18:533–544
  20. Belgorosky D, Sander VA, Yorio MP, Faletti AG, Motta AB. Hyperandrogenism alters intraovarian parameters during early folliculogenesis in mice. Reprod Biomed Online. 2010;20:797–807
  21. Dupont J, Chabrolle C, Ramé C, Tosca L, Coyral-Castel S. Role of the peroxisome proliferator-activated receptors, adenosine monophosphate-activated kinase, and adiponectin in the ovary. PPAR Res. 2008;2008:176275
  22. Motta AB, Estévez A, Tognetti T, Gimeno MA, Franchi AM. Dual effect of nitric oxide in functional and regressing rat corpus luteum. Mol Hum Reprod. 2001;7:43–47
  23. Irusta G, Parborell F, Peluffo M, Manna PR, Gonzalez-Calvar SI, Calandra R, et al. Steroidogenic acute regulatory protein in ovarian follicles of gonadotropin-stimulated rats is regulated by a gonadotropin-releasing hormone agonist. Biol Reprod. 2003;68:1577–1583
  24. Solano ME, Sander V, Wald MR, Motta AB. Dehydroepiandrosterone and metformin regulate proliferation of murine T lymphocytes. Clin Exp Immunol. 2008;153:289–296
  25. Parborell F, Abramovich D, Tesone M. Intrabursal administration of the antiangiopoietin 1 antibody produces a delay in rat follicular development associated with an increase in ovarian apoptosis mediated by changes in the expression of BCL2 related genes. Biol Reprod. 2008;78:506–513
  26. Gasic S, Bodenburg Y, Nagamani M, Green A, Urban RJ. Troglitazone inhibits progesterone production in porcine granulosa cells. Endocrinology. 1998;139:4962–4966
  27. Komar CM, Braissant O, Wahli W, Curry TE. Expression and localization of PPARs in the rat ovary during follicular development and the periovulatory period. Endocrinology. 2001;142:4831–4838
  28. San-Millán JL, Escobar-Morreale HF. The role of genetic variation in peroxisome proliferator-activated receptors in the polycystic ovary syndrome (PCOS): an original case-control study followed by systematic review and meta-analysis of existing evidence. Clin Endocrinol (Oxf). 2010;72:383–392
  29. Day C. Thiazolidinediones: a new class of antidiabetic drugs. Diabet Med. 1999;16:179–192
  30. Iuorno MJ, Nestler JE. Insulin-lowering drugs in polycystic ovary syndrome. Obstet Gynecol Clin North Am. 2001;28:153–164
  31. Girard J. Mechanisms of action of thiazolidinediones. Diabetes Metab. 2001;27(2 Pt 2):271–278
  32. Seli E, Duleba AJ. Treatment of PCOS with metformin and other insulin-sensitizing agents. Curr Diab Rep. 2004;4:69–75
  33. Minge CE, Ryan NK, Van Der Hoek KH, Robker RL, Norman RJ. Troglitazone regulates peroxisome proliferator-activated receptors and inducible nitric oxide synthase in murine ovarian macrophages. Biol Reprod. 2006;74:153–160
  34. Brannian JD, Eyster KM, Weber M, Diggins M. Pioglitazone administration alters ovarian gene expression in aging obese lethal yellow mice. Reprod Biol Endocrinol. 2008;18:6–10
  35. Sander VA, Facorro GB, Piehl L, Rubín de Celis E, Motta AB. Effect of DHEA and metformin on corpus luteum in mice. Reproduction. 2009;138:571–579
  36. Simpson ER, McCarthy JL, Peterson JA. Evidence that the cycloheximide-sensitive site of adrenocorticotropic hormone action is in the mitochondrion. Changes in pregnenolone formation, cholesterol content, and the electron paramagnetic resonance spectra of cytochrome P-450. J Biol Chem. 1978;253:3135–3139
  37. Stocco DM, Clark BJ. Role of the steroidogenic acute regulatory protein (StAR) in steroidogenesis. Biochem Pharmacol. 1996;51:197–205
  38. Stocco DM, Clark BJ. Regulation of the acute production of steroids in steroidogenic cells. Endocr Rev. 1996;17:221–244
  39. Stocco DM. The steroidogenic acute regulatory (StAR) protein two years later. An update. Endocrine. 1997;6:99–109
  40. Devoto L, Kohen P, Vega M, Castro O, González RR, Retamales I, et al. Control of human luteal steroidogenesis. Mol Cell Endocrinol. 2002;186:137–141
  41. Yazawa T, Inaoka Y, Okada R, Mizutani T, Yamazaki Y, Usami Y, et al. PPAR-gamma coactivator-1alpha regulates progesterone production in ovarian granulosa cells with SF-1 and LRH-1. Mol Endocrinol. 2010;24:485–496
  42. Li MY, Yuan H, Ma LT, Kong AW, Hsin MK, Yip J, et al. Roles of PPAR{alpha} and PPAR{gamma} in the development of non-small cell lung cancer. Am J Respir Cell Mol Biol. 2010;[Epub ahead of print]
  43. Yan KH, Yao CJ, Chang HY, Lai GM, Cheng AL, Chuang SE. The synergistic anticancer effect of troglitazone combined with aspirin causes cell cycle arrest and apoptosis in human lung cancer cells. Mol Carcinog. 2010;49:235–246
  44. Shim J, Kim BH, Kim YI, Kim KY, Hwangbo Y, Jang JY, et al. The peroxisome proliferator-activated receptor gamma ligands, pioglitazone and 15-deoxy-Delta(12,14)-prostaglandin J(2), have antineoplastic effects against hepatitis B virus-associated hepatocellular carcinoma cells. Int J Oncol. 2010;36:223–231
  45. Park SH. Current status of liver disease in Korea: nonalcoholic fatty liver disease. Korean J Hepatol. 2009;15:34–39
  46. Milkevitch M, Beardsley NJ, Delikatny EJ. Phenylbutyrate induces apoptosis and lipid accumulations via a peroxisome proliferator-activated receptor gamma-dependent pathway. NMR Biomed. 2010;23:473–479
  47. Bruedigam C, Eijken M, Koedam M, van de Peppel J, Drabek K, Chiba H, et al. A new concept underlying stem cell lineage skewing that explains the detrimental effects of thiazolidinediones on bone. Stem Cells. 2010;28:916–927
  48. Chen Q, Sun X, Chen J, Cheng L, Wang J, Wang Y, et al. Direct rosiglitazone action on steroidogenesis and proinflammatory factor production in human granulosa-lutein cells. Reprod Biol Endocrinol. 2009;7:147

 M.F. has nothing to disclose. E.M.E. has nothing to disclose. F.P. has nothing to disclose. N.C.C. has nothing to disclose. M.T. has nothing to disclose. A.B.M. has nothing to disclose.

 Supported by Agencia Nacional de Promoción Científica y Tecnológica (grants PICTR 32529/05 and PICT 949/06) and the PIP 185 from Consejo Nacional de Investigación Científica y Técnica.

PII: S0015-0282(10)02209-0

doi: 10.1016/j.fertnstert.2010.07.1083

Fertility and Sterility
Volume 95, Issue 1 , Pages 333-337 , January 2011

Article Tools

* Image Usage & Resolution